Evidence map›Paper›PMID 35363053›Full record

ArticleJournal of palliative medicine2022

Aggressive End-of-Life Care in the Veterans Health Administration versus Fee-for-Service Medicare among Patients with Advanced Lung Cancer.

Carolyn J Presley, Kiranveer Kaur, Ling Han, Pamela R Soulos, Weiwei Zhu, Emily Corneau, John R O'Leary, Herta Chao, Tracy Shamas, Michal G Rose and 4 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of palliative medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Carolyn J PresleyDivision of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0002-2607-5639
Kiranveer KaurDivision of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.
Ling HanDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Pamela R SoulosDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Weiwei ZhuDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Emily CorneauCenter of Innovation, Providence Veterans Health Administration (VA) Medical Center, Providence, Rhode Island, USA.
John R O'LearyDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Herta ChaoDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Tracy ShamasConnecticut Veterans Health Administration, West Haven, Connecticut, USA.
Michal G RoseDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Karl A LorenzCenter for Innovation to Implementation, VA Palo Alto Healthcare System, Palo Alto, California, USA.
Cari R LevyEastern Colorado VA Healthcare System, Aurora, Colorado, USA.
Vincent MorCenter of Innovation, Providence Veterans Health Administration (VA) Medical Center, Providence, Rhode Island, USA.
Cary P GrossDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Yale University · USYale Cancer Center · USThe Ohio State University · USBrown University · USProvidence VA Medical Center · USVA Connecticut Healthcare System · USVA Eastern Colorado Health Care System · USVA Palo Alto Health Care System · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung CancerP50CA196530 · NCI · YALE UNIVERSITY · PI Shuangge Ma · 2015 to 2026
$31.1M
Translational Training Grant in Experimental TherapeuticsK12CA133250 · NCI · OHIO STATE UNIVERSITY · PI WILLIAM E. CARSON, Rosa Lapalombella · 2008 to 2026
$15.0M
NCATS NIH HHS UL1 TR001863NCI NIH HHS K12 CA133250NCI NIH HHS N01 PC035136NCI NIH HHS N01 PC035139NCI NIH HHS N02 PC015105NCI NIH HHS P50 CA196530
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungHospice CareLung NeoplasmsTerminal CareAgedDeathHumansMedicareUnited StatesVeterans Healthcancerhospice carehospital referral regionnonsmall cell lung cancertreatment

Identifiers

PMID35363053
PMCPMC9360181
OpenAlexW4220816342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.